Trial Profile

Corticotrophin Releasing Factor 2 for the Treatment of Worsening Heart Failure (WHF) - the CRAFT-WHF Study

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 07 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs COR 1167 (Primary)
Indications Heart failure
Focus Therapeutic Use
Acronyms CRAFT-WHF
Sponsors Corteria Pharmaceuticals

Most Recent Events

12 Aug 2025 Status changed from not, yet recruiting to recruiting.
14 Feb 2025 According to Corteria Pharmaceuticals media release , company announces the initiation of this trial.
14 Feb 2025 According to Corteria Pharmaceuticals media release , the company anticipates completing the Phase 1 study in the first half of 2025, to be followed by the initiation of a Phase 2 study in this indication.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com